Cargando…

Comparison of late gadolinium enhancement patterns in different forms of cardiac amyloidosis

Detalles Bibliográficos
Autores principales:	Kammerer, Rebekka, Scherer, Katrin A, aus dem Siepen, Fabian, Bauer, Ralf, Hardt, Stefan E, Buss, Sebastian, Kristen, Arnt V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559663/ http://dx.doi.org/10.1186/1532-429X-15-S1-P120

Ejemplares similares

Thickness of the midventricular left ventricular wall is predictive of survival in different forms of cardiac amyloidosis
por: aus dem Siepen, Fabian, et al.
Publicado: (2013)

Non-invasive risk stratification of patients with TTR amyloidosis
por: Scherer, Katrin A, et al.
Publicado: (2013)

Wild-type transthyretin amyloidosis in female patients
por: Kristen, Arnt V, et al.
Publicado: (2015)

Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study
por: Siepen, Fabian aus dem, et al.
Publicado: (2015)

Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms
por: Korosoglou, Grigorios, et al.
Publicado: (2021)

T1 mapping: useful for treatment monitoring in patients with senile systemic amyloidosis?
por: dem Siepen, Fabian aus, et al.
Publicado: (2014)

Elevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis
por: Hein, Selina J, et al.
Publicado: (2021)

Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis
por: Arenja, Nisha, et al.
Publicado: (2019)

Feature tracking cardiac magnetic resonance in systemic light chain amyloidosis
por: Kammerer, Rebekka, et al.
Publicado: (2013)

Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia
por: Dittrich, Tobias, et al.
Publicado: (2019)

Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis
por: Hein, Selina, et al.
Publicado: (2021)

Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis
por: Ochs, Marco M., et al.
Publicado: (2017)

Cardiac magnetic resonance strain imaging in systemic light chain amyloidosis
por: Andre, Florian, et al.
Publicado: (2014)

Assessment of myocardial strain in patients with myocarditis by cardiac magnetic resonance imaging
por: Andre, Florian, et al.
Publicado: (2014)

Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy
por: Aurich, Matthias, et al.
Publicado: (2023)

Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis
por: Hoerbrand, Isabel A., et al.
Publicado: (2022)

Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)
por: Yilmaz, A., et al.
Publicado: (2021)

Diffuse myocardial fibrosis in early forms of dilated cardiomyopathy: insights from T1 mapping cardiovascular magnetic resonance
por: aus dem Siepen, Fabian, et al.
Publicado: (2013)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
por: Dungu, Jason, et al.
Publicado: (2012)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Extracellular volume assessed by CMR T1-mapping correlates with histologically determined amount of diffuse fibrosis in DCM
por: aus dem Siepen, Fabian, et al.
Publicado: (2014)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
por: Hees, Tilman A, et al.
Publicado: (2013)

Prognostic utility of late gadolinium enhancement on cardiac magnetic resonance in cardiac amyloidosis: a meta-analysis
por: Raina, Sameer, et al.
Publicado: (2016)

MRI detected mass decrease in patients with amyloidosis after treatment with green tea: a one year follow-up study
por: Buss, Sebastian, et al.
Publicado: (2012)

Green tea halts progression of cardiac transthyretin amyloidosis: an observational report
por: Kristen, Arnt V., et al.
Publicado: (2012)

Non-invasive measurement of myocardial extracellular volume using T1 mapping as a novel biomarker of diffuse fibrosis in dilated cardiomyopathy
por: aus dem Siepen, Fabian, et al.
Publicado: (2013)

Role of cardiovascular magnetic resonance in suspected cardiac amyloidosis: late gadolinium enhancement pattern as mortality predictor
por: Baroni, M., et al.
Publicado: (2017)

Increase of myocardial infarctions over the years after heart transplantation detected by late gadolinium enhanced MRI
por: Braggion Santos, Maria Fernanda, et al.
Publicado: (2013)

Feasibility of high dose dobutamine stress and scar imaging in high field open MRI in patients with suspected coronary artery disease
por: Petry, Phillip G, et al.
Publicado: (2013)

Standardized assessment of global longitudinal and circumferential strain - a modality independent software approach
por: Riffel, Johannes, et al.
Publicado: (2015)

Variability of cardiovascular magnetic resonance (CMR) T1 mapping parameters in healthy volunteers during long-term follow-up
por: aus dem Siepen, Fabian, et al.
Publicado: (2018)

Z-score mapping for standardized analysis and reporting of cardiovascular magnetic resonance modified Look-Locker inversion recovery (MOLLI) T1 data: Normal behavior and validation in patients with amyloidosis
por: Kranzusch, Riccardo, et al.
Publicado: (2020)

Cardiac phase-resolved late gadolinium enhancement imaging
por: Weingärtner, Sebastian, et al.
Publicado: (2022)

Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up
por: Migrino, Raymond Q, et al.
Publicado: (2009)

Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics
por: Williams, Lynne K., et al.
Publicado: (2017)

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
por: Kristen, Arnt V., et al.
Publicado: (2017)

3.0T cardiac magnetic resonance quantification of native T1 and myocardial extracellular volume for the diagnosis of late gadolinium enhancement-negative cardiac amyloidosis
por: Liu, Yumeng, et al.
Publicado: (2022)

Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy?
por: Riffel, Johannes H., et al.
Publicado: (2016)

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019)

Right ventricular function in dilated cardiomyopathy: relation to location of focal myocardial fibrosis
por: Abdelrazek, Mohamed A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fkret4tcv8ogg7l0j6utmf215j